Anthony Grosso has been appointed to the role of Head of Scientific Affairs [SA] at Accord Healthcare Europe.
August 28, 2019, Harrow, UK – Anthony Grosso has been appointed to the role of Head of Scientific Affairs [SA] at Accord Healthcare Europe. Dr Grosso will be responsible for overseeing Accord’s strategy for sustained patient access to innovative, added-value, cost-effective and critical medicines. He will report to James Burt Executive Vice-President, Europe and MENA at Accord. Dr Grosso has previously held senior public and commercial roles including Principal Medicines Management Pharmacist/Honorary Associate Professorat UCL Hospitals/UCL and Medical Director and VP level positions within Medical Affairs.
Dr Grosso is a registered pharmacist with a First-Class BSc (Hons) from Brighton, an MSc with Distinction from Belfast and a PhD from London. He has a long-standing interest in the efficient use of medicines, in particular with biologics, generics and biosimilars, which has led to him authoring numerous publications in these areas.
“We are thrilled to have Anthony join our senior team at Accord,” said Dr Burt. “There is a real opportunity to improve patient access to high quality medicines and for generics companies like us to drive the development of added-value medical innovations – we are always looking to make it better for healthcare systems and ultimately patients. Anthony’s experience in running pharmaceutical businesses and his time at the coal-face of pharmacy delivery will help us achieve these goals and adds to our burgeoning team of generics and biosimilar specialists.”
“Scientific Affairs is a new function at Accord Healthcare which encompasses regulatory and medical affairs, medicines information, healthcare compliance, pharmacovigilance and drug safety. I am delighted to have been given the opportunity to build and lead this function with a prime focus being to help improve patient care,” said Dr Grosso.
About Accord Healthcare Europe
Headquartered in the United Kingdom (UK), Accord Healthcare Europe is one of the fastest growing generic pharmaceutical companies in Europe. We have one of the largest market footprints of any European generic company selling generic medicines in over 80 countries around the world.
This global footprint enables us to deliver vital, affordable medicines worldwide, to the national health systems and patients who need them most.
Our approach is agile and inventive, always seeking to improve our products and patients’ access to them. We’re driven to think differently and deliver more for the benefit of patients worldwide.
Accord, we make it better www.accord-healthcare.com
